Financial News
Articles published by Amneal Pharmaceuticals, Inc.
Amneal Appoints Deborah M. Autor to Board of Directors
August 03, 2022
Via Business Wire
Tickers
AMRX
Via Business Wire
Tickers
AMRX
Via Business Wire
Tickers
AMRX
Via Business Wire
Tickers
AMRX
Via Business Wire
Tickers
AMRX
Via Business Wire
Tickers
AMRX
Amneal to Report First Quarter 2022 Results on May 4, 2022
April 07, 2022
Via Business Wire
Tickers
AMRX
Amneal Expands Injectables Portfolio with 4 New Products
February 17, 2022
Via Business Wire
Tickers
AMRX
Via Business Wire
Tickers
AMRX
Amneal Acquires Saol Therapeutics’ Baclofen Franchise
January 05, 2022
Via Business Wire
Tickers
AMRX
Amneal to Virtually Participate at the 40th Annual J.P. Morgan Healthcare Conference
December 21, 2021
Via Business Wire
Tickers
AMRX
Amneal Receives Approval for Difluprednate Ophthalmic Emulsion
November 19, 2021
Via Business Wire
Tickers
AMRX
Amneal to Virtually Participate at Upcoming Investor Conferences
November 12, 2021
Via Business Wire
Tickers
AMRX
Amneal Reports Third Quarter 2021 Financial Results
November 03, 2021
Via Business Wire
Tickers
AMRX
Amneal Launches Generic Dexamethasone Following ANDA Approval by FDA
October 27, 2021
Via Business Wire
Tickers
AMRX
Amneal to Report Third Quarter 2021 Results on November 3, 2021
October 06, 2021
Via Business Wire
Tickers
AMRX
Amneal to Virtually Participate at Morgan Stanley 19th Annual Global Healthcare Conference
September 07, 2021
Via Business Wire
Tickers
AMRX
Via Business Wire
Tickers
AMRX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.